Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.72 USD | +1.03% | +1.03% | -19.51% |
19/04 | Pieris Pharmaceuticals Shares Fall After 1-for-80 Reverse Stock Split Announcement | MT |
03/04 | North American Morning Briefing : Powell Awaited -2- | DJ |
Business Summary
Number of employees: 48
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biotechnological Applications
100.0
%
| 26 | 100.0 % | 43 | 100.0 % | +65.28% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States, Germany and Australia
100.0
%
| 26 | 100.0 % | 43 | 100.0 % | +65.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Yoder
CEO | Chief Executive Officer | 48 | 01/10/01 |
Thomas Bures
DFI | Director of Finance/CFO | 49 | 01/17/01 |
Kayti Aviano
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Hitto Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 53 | 30/19/30 |
Shane Olwill
PRN | Corporate Officer/Principal | 48 | 01/11/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20/16/20 | |
James Geraghty
CHM | Chairman | 70 | 22/17/22 |
Michael Richman
BRD | Director/Board Member | 63 | 17/14/17 |
Matthew Sherman
BRD | Director/Board Member | 68 | 25/18/25 |
Peter Kiener
BRD | Director/Board Member | 72 | 10/18/10 |
Stephen Yoder
CEO | Chief Executive Officer | 48 | 01/10/01 |
Maya Said
BRD | Director/Board Member | 47 | 31/19/31 |
Ann Barbier
BRD | Director/Board Member | 59 | 25/18/25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,506 | 0 | 0 | 92.57 % |
Stock B | 0 | 4,026 | 0 | 0 | |
Stock C | 1 | 1,236,688 | 1,144,742 ( 92.57 %) | 0 | |
Stock D | 0 | 85 | 0 | 0 |
Company contact information
Pieris Pharmaceuticals, Inc.
225 Franklin Street 9th floor
02109, Boston
+857 246 8998
http://www.pieris.comSector
1st Jan change | Capi. | |
---|---|---|
-19.51% | 14.49M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- PIRS Stock
- Company Pieris Pharmaceuticals, Inc.